Search results
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 21,000 ...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 20 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Market Watch· 2 days agoPublished: June 12, 2024 at 6:01 p.m. ETShareResizeBy Ben GlickmanAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children ...
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 7 days agoThe endorsement follows a review of AstraZeneca's financial model after the company presented...
AstraZeneca CEO gifts shares to family, no sale involved By Investing.com
Investing.com· 2 days agoAstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) disclosed in a recent regulatory filing with the...
Ethic Inc. Grows Stake in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoEthic Inc. lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The ...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 4 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, ...
Centessa Pharma Hires CFO from Fusion After AstraZeneca Takeover
Market Watch· 4 days agoPublished: June 10, 2024 at 7:37 a.m. ETShareResizeBy Dean SealCentessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired ...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 23 hours agoRivals Face Off With Regeneron Stock The companies are far from alone in the burgeoning COPD...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 7 days agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome ...